Benjamini O, Tadmor T, Avigdor A, Gershon R, et al. Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia. Acta Haematol 2024 Mar 12. doi: 10.1159/000537690.
PMID: 38471491